Literature DB >> 20722838

The role of tumor necrosis factor-alpha in cognitive improvement after peroxisome proliferator-activator receptor gamma agonist pioglitazone treatment in Alzheimer's disease.

Haruo Hanyu, Tomohiko Sato, Hirofumi Sakurai, Toshihiko Iwamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20722838     DOI： 10.1111/j.1532-5415.2010.02841.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  8 in total

Review 1.  Insulin, cognition, and dementia.

Authors:  Brenna Cholerton; Laura D Baker; Suzanne Craft
Journal:  Eur J Pharmacol       Date:  2013-09-23       Impact factor: 4.432

Review 2.  Peroxisome proliferator-activated receptor-gamma agonists for Alzheimer's disease and amnestic mild cognitive impairment: a systematic review and meta-analysis.

Authors:  Jia Liu; Lu-ning Wang; Jian-ping Jia
Journal:  Drugs Aging       Date:  2015-01       Impact factor: 3.923

Review 3.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

4.  Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice.

Authors:  Magali Dumont; Cliona Stack; Ceyhan Elipenahli; Shari Jainuddin; Meri Gerges; Natalia Starkova; Noel Y Calingasan; Lichuan Yang; Davide Tampellini; Anatoly A Starkov; Robin B Chan; Gilbert Di Paolo; Aurora Pujol; M Flint Beal
Journal:  Hum Mol Genet       Date:  2012-08-24       Impact factor: 6.150

Review 5.  Modulating microglia activity with PPAR-γ agonists: a promising therapy for Parkinson's disease?

Authors:  Anna R Carta; Augusta Pisanu
Journal:  Neurotox Res       Date:  2012-08-07       Impact factor: 3.911

6.  The Role of Oxidized Cholesterol in Diabetes-Induced Lysosomal Dysfunction in the Brain.

Authors:  Catrina Sims-Robinson; Anna Bakeman; Andrew Rosko; Rebecca Glasser; Eva L Feldman
Journal:  Mol Neurobiol       Date:  2015-05-15       Impact factor: 5.590

7.  Activated PPARγ Abrogates Misprocessing of Amyloid Precursor Protein, Tau Missorting and Synaptotoxicity.

Authors:  Susanne Moosecker; Patrícia Gomes; Chrysoula Dioli; Shuang Yu; Ioannis Sotiropoulos; Osborne F X Almeida
Journal:  Front Cell Neurosci       Date:  2019-06-12       Impact factor: 5.505

8.  An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease.

Authors:  Raj C Shah; Dawn C Matthews; Randolph D Andrews; Ana W Capuano; Debra A Fleischman; James T VanderLugt; Jerry R Colca
Journal:  Curr Alzheimer Res       Date:  2014       Impact factor: 3.498
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.